We detected the expression level of p-AKT and found that the level of p-AKT was significantly lower than that of the control (Fig. 5B), indicating that Bufalin affected the development of gallbladder cancer by influencing the PI3-K/Akt and MEK/ERK signaling pathways. This evidence concerns the gene MAP2K7 and gallbladder cancer.